• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PracSys and NASI clash over linacs

Article

PracSys of Salem, NH, last month entered a claim with the American Arbitration Association against North American Scientific regarding a linear accelerator supply deal between the companies that broke down. PracSys filed the complaint on June 16, after

PracSys of Salem, NH, last month entered a claim with the American Arbitration Association against North American Scientific regarding a linear accelerator supply deal between the companies that broke down. PracSys filed the complaint on June 16, after its attempts to resolve a contract dispute with NASI failed.

PracSys and North American Scientific signed a supply deal last year in which North American agreed to pay PracSys $2.7 million for two linear accelerators (SCAN 3/4/98). North American Scientific planned to use the accelerators to produce palladium-103 for the manufacture of prostate brachytherapy seeds.

But the partnership soured six months ago, according to PracSys. The company’s complaint states that after the agreement with North American Scientific was signed, NASI signed a contract with another vendor for the supply of palladium, and reneged on its obligation to provide a lease guaranty crucial to the PracSys deal. PracSys claims that North American Scientific’s actions prevented it from fulfilling its contract, and the company seeks damages of $3 million.

PracSys’ claim is meritless, North American Scientific executives told SCAN. In a statement also released June 16, the Chatsworth, CA, company declared that it has realized its obligations under the 1998 contract with PracSys, and announced that it has asked PracSys to turn over the uncompleted linear accelerators—for which NASI claims it has paid in full. North American Scientific will install and finish them itself, the company said.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.